Cardiology
-
A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.
-
Parents’ PTSD after child’s medical trauma
Nearly half of parents with a child who received an implantable device to correct abnormal heart rhythms met criteria for post-traumatic stress disorder, a Stanford Medicine-led study found.
-
Stanford Health Care among nation’s top hospitals
For eighth year running, U.S. News & World Report ranks Stanford Health Care one of the nation’s highest-rated hospitals.
-
Joseph Wu to be AHA president
Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.
-
Marijuana can damage heart
Marijuana use and heart-attack risk were correlated in a large human study, Stanford scientists and their collaborators found. A molecule in soybeans may counteract these effects.
-
Fiber supplements’ effects differ
Researchers found that one fiber supplement seemed helpful while another appeared harmful — but study participants’ reactions varied.
-
Stanford ranks high for complex heart procedures
For patients like Nathan Foss, Stanford’s expertise in rare and complicated heart surgeries provides better options.
-
500th heart transplant at Stanford
Mackenzie Collins was the 500th pediatric patient to undergo a heart transplant at Stanford Medicine.
-
Diversity key to cholesterol risk prediction
A Stanford study shows that using genomes from a diverse pool of people improves the ability to predict an individual’s risk of having high cholesterol.
-
Bypass surgery vs. stenting
Among heart-disease patients in a study who received stents, the incidence of a major complication — death, heart attack, stroke or the need for a repeat procedure — was 10.6% after a year. Among bypass patients, the rate was 6.9%.
-
Surgery for hard-to-treat atrial fibrillation
Silas Richardson was in the hospital with a heart rhythm disorder that his doctors couldn’t get under control. Surgery at Stanford Health Care – ValleyCare solved the problem.
-
$31 million for stem cell clinical trials
The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.
- Artificial Intelligence (AI)
- Addiction
- Aging & Geriatrics
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Awards & Honors
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Disease
- Innovation & Technology
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obituaries
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health